278 related articles for article (PubMed ID: 36362034)
1. CADMA-Chem: A Computational Protocol Based on Chemical Properties Aimed to Design Multifunctional Antioxidants.
Guzman-Lopez EG; Reina M; Perez-Gonzalez A; Francisco-Marquez M; Hernandez-Ayala LF; Castañeda-Arriaga R; Galano A
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362034
[TBL] [Abstract][Full Text] [Related]
2. Rational Design of Multifunctional Ferulic Acid Derivatives Aimed for Alzheimer's and Parkinson's Diseases.
Guzmán-López EG; Reina M; Hernández-Ayala LF; Galano A
Antioxidants (Basel); 2023 Jun; 12(6):. PubMed ID: 37371986
[TBL] [Abstract][Full Text] [Related]
3. Chalcone Derivatives with a High Potential as Multifunctional Antioxidant Neuroprotectors.
Pérez-González A; Castañeda-Arriaga R; Guzmán-López EG; Hernández-Ayala LF; Galano A
ACS Omega; 2022 Nov; 7(43):38254-38268. PubMed ID: 36340167
[TBL] [Abstract][Full Text] [Related]
4. Quinoline Derivatives: Promising Antioxidants with Neuroprotective Potential.
Hernández-Ayala LF; Guzmán-López EG; Galano A
Antioxidants (Basel); 2023 Oct; 12(10):. PubMed ID: 37891932
[TBL] [Abstract][Full Text] [Related]
5. Management of oxidative stress and other pathologies in Alzheimer's disease.
Simunkova M; Alwasel SH; Alhazza IM; Jomova K; Kollar V; Rusko M; Valko M
Arch Toxicol; 2019 Sep; 93(9):2491-2513. PubMed ID: 31440798
[TBL] [Abstract][Full Text] [Related]
6. Pyridoxine-resveratrol hybrids Mannich base derivatives as novel dual inhibitors of AChE and MAO-B with antioxidant and metal-chelating properties for the treatment of Alzheimer's disease.
Yang X; Qiang X; Li Y; Luo L; Xu R; Zheng Y; Cao Z; Tan Z; Deng Y
Bioorg Chem; 2017 Apr; 71():305-314. PubMed ID: 28267984
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic Insight into the Design of Chemical Tools to Control Multiple Pathogenic Features in Alzheimer's Disease.
Han J; Du Z; Lim MH
Acc Chem Res; 2021 Oct; 54(20):3930-3940. PubMed ID: 34606227
[TBL] [Abstract][Full Text] [Related]
8. Tacrine-melatonin hybrids as multifunctional agents for Alzheimer's disease, with cholinergic, antioxidant, and neuroprotective properties.
Fernández-Bachiller MI; Pérez C; Campillo NE; Páez JA; González-Muñoz GC; Usán P; García-Palomero E; López MG; Villarroya M; García AG; Martínez A; Rodríguez-Franco MI
ChemMedChem; 2009 May; 4(5):828-41. PubMed ID: 19308922
[TBL] [Abstract][Full Text] [Related]
9. New multifunctional melatonin-derived benzylpyridinium bromides with potent cholinergic, antioxidant, and neuroprotective properties as innovative drugs for Alzheimer's disease.
Luo XT; Wang CM; Liu Y; Huang ZG
Eur J Med Chem; 2015 Oct; 103():302-11. PubMed ID: 26363866
[TBL] [Abstract][Full Text] [Related]
10. Development of cyanopyridine-triazine hybrids as lead multitarget anti-Alzheimer agents.
Maqbool M; Manral A; Jameel E; Kumar J; Saini V; Shandilya A; Tiwari M; Hoda N; Jayaram B
Bioorg Med Chem; 2016 Jun; 24(12):2777-88. PubMed ID: 27157006
[TBL] [Abstract][Full Text] [Related]
11. 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment.
Makhaeva GF; Lushchekina SV; Boltneva NP; Serebryakova OG; Rudakova EV; Ustyugov AA; Bachurin SO; Shchepochkin AV; Chupakhin ON; Charushin VN; Richardson RJ
Bioorg Med Chem; 2017 Nov; 25(21):5981-5994. PubMed ID: 28986116
[TBL] [Abstract][Full Text] [Related]
12. Serotonin 5-HT
Więckowski K; Szałaj N; Gryzło B; Wichur T; Góral I; Sługocka E; Sniecikowska J; Latacz G; Siwek A; Godyń J; Bucki A; Kołaczkowski M; Więckowska A
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012707
[TBL] [Abstract][Full Text] [Related]
13. Donepezil-butylated hydroxytoluene (BHT) hybrids as Anti-Alzheimer's disease agents with cholinergic, antioxidant, and neuroprotective properties.
Cai P; Fang SQ; Yang HL; Yang XL; Liu QH; Kong LY; Wang XB
Eur J Med Chem; 2018 Sep; 157():161-176. PubMed ID: 30096650
[TBL] [Abstract][Full Text] [Related]
14. Rational Design and Multibiological Profiling of Novel Donepezil-Trolox Hybrids against Alzheimer's Disease, with Cholinergic, Antioxidant, Neuroprotective, and Cognition Enhancing Properties.
Cai P; Fang SQ; Yang XL; Wu JJ; Liu QH; Hong H; Wang XB; Kong LY
ACS Chem Neurosci; 2017 Nov; 8(11):2496-2511. PubMed ID: 28806057
[TBL] [Abstract][Full Text] [Related]
15. Boosting caffeic acid performance as antioxidant and monoamine oxidase B/catechol-O-methyltransferase inhibitor.
Chavarria D; Benfeito S; Soares P; Lima C; Garrido J; Serrão P; Soares-da-Silva P; Remião F; Oliveira PJ; Borges F
Eur J Med Chem; 2022 Dec; 243():114740. PubMed ID: 36116233
[TBL] [Abstract][Full Text] [Related]
16. Multifunctional 5,6-dimethoxybenzo[d]isothiazol-3(2H)-one-N-alkylbenzylamine derivatives with acetylcholinesterase, monoamine oxidases and β-amyloid aggregation inhibitory activities as potential agents against Alzheimer's disease.
Xu R; Xiao G; Li Y; Liu H; Song Q; Zhang X; Yang Z; Zheng Y; Tan Z; Deng Y
Bioorg Med Chem; 2018 May; 26(8):1885-1895. PubMed ID: 29500132
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, biological evaluation and molecular modeling study of novel tacrine-carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.
Thiratmatrakul S; Yenjai C; Waiwut P; Vajragupta O; Reubroycharoen P; Tohda M; Boonyarat C
Eur J Med Chem; 2014 Mar; 75():21-30. PubMed ID: 24508831
[TBL] [Abstract][Full Text] [Related]
18. Computational approach to suggest a new multi-target-directed ligand as a potential medication for Alzheimer's disease.
Eslami M; Nezafat N; Negahdaripour M; Ghasemi Y
J Biomol Struct Dyn; 2019 Nov; 37(18):4825-4839. PubMed ID: 30689517
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and evaluation of scutellarein-O-alkylamines as multifunctional agents for the treatment of Alzheimer's disease.
Sang Z; Qiang X; Li Y; Yuan W; Liu Q; Shi Y; Ang W; Luo Y; Tan Z; Deng Y
Eur J Med Chem; 2015 Apr; 94():348-66. PubMed ID: 25778991
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory potential of plant secondary metabolites on anti-Parkinsonian drug targets: Relevance to pathophysiology, and motor and non-motor behavioural abnormalities.
Mazumder MK; Borah A; Choudhury S
Med Hypotheses; 2020 Apr; 137():109544. PubMed ID: 31954292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
